Deck-chair sign: unreserved

B D van Rhijn^{1

2}, S van Ruth², D M W Balak^{1

3}

Affiliations

¹ Department of Dermatology and Allergology, UMC Utrecht, Utrecht, The Netherlands.
² Department of Dermatology, Tergooi, Hilversum, The Netherlands.
³ Department of Dermatology, LangeLand Ziekenhuis, Zoetermeer, The Netherlands.

Case Reports

B D van Rhijn et al. Clin Exp Dermatol. 2021 Apr.

. 2021 Apr;46(3):560-561.

doi: 10.1111/ced.14457. Epub 2020 Oct 10.

B D van Rhijn^{1

2}, S van Ruth², D M W Balak^{1

3}

¹ Department of Dermatology and Allergology, UMC Utrecht, Utrecht, The Netherlands.
² Department of Dermatology, Tergooi, Hilversum, The Netherlands.
³ Department of Dermatology, LangeLand Ziekenhuis, Zoetermeer, The Netherlands.

No abstract available

References

1. Ofuji S, Furukawa F, Miyachi Y, Ohno S. Papuloerythroderma. Dermatologica 1984; 169: 125-30.
1. Pal S, Haroon TS. Erythroderma: a clinico-etiologic study of 90 cases. Int J Dermatol 1998; 37: 104-7.
1. Banka N, Aljurf M, Hamadah I. Imatinib (STI-571)-induced exfoliative dermatitis in a Saudi patient with deck chair sign. Dermatology 2003; 207: 329-30.
1. Bettoli V, Pizzigoni S, Borghi A, Virgili A. Ofuji papuloerythroderma: a reappraisal of the deck-chair sign. Dermatology 2004; 209: 1-4.
1. Wernham AG, Fremlin GA, Orpin SD, Salim A. Physician, beware! The deckchair sign can be seen in dermatomyositis. Clin Exp Dermatol 2016; 41: 919-20.